Stran & Company, Inc. (“Stran” or the “Company”) (NASDAQ: STRN) (NASDAQ: STRNW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise. Over the past 25 years, Stran has grown to become a leader in the promotional products industry, specializing in complex marketing programs to help recognize the value of promotional products, branded merchandise and loyalty incentive programs as a tool to drive awareness, build brands and impact sales. Stran is the chosen partner of many Fortune 500 companies, across a variety of industries, to execute their promotional marketing, loyalty and incentive, sponsorship activation, recruitment, retention, and wellness campaigns. Stran provides world-class customer service and utilizes cutting-edge technology, including efficient ordering and logistics technology to provide order processing, warehousing and fulfillment functions. The Company’s mission is to develop long-term relationships with its clients, enabling them to connect with both their customers and employees in order to build lasting brand loyalty.

Stran & Company recently Secured Multi-Year Contract with Large National Healthcare Company.

. 

Andy Shape, President and CEO of Stran, commented, “We are pleased to be selected by this premier healthcare company, which reflects our traction in the market. We believe this selection also validates our ability to address the complex marketing needs of our customers. The healthcare industry is among the top industries utilizing promotional products as a marketing tool to increase brand awareness and engage with consumers. We believe the healthcare market represents a significant, yet largely untapped, opportunity to utilize promotional products to help drive positive and healthy consumer behaviors. We look forward to working closely with this customer and anticipate this contract will drive significant annual revenue for Stran with potential expansion opportunities.”

Zack Morris posted his current holding of $STRN on Twitter; that is the huge bet. He is not selling it under $10.

 REVENUE GROWTH

 The company has been generating higher revenue year over year. They are also earning pretty good profits consistently. 

Combinations of low float, high short interest, expensive short borrow fee, massive insiders ownership will create Gamma squeeze; it will push the share price beyond $10 a share.